| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.09 | 0.05 |